New corneal therapies: From Bench to BedsideProfessor Keith MeekProfessor and Chair of Structural Biophysics Research GroupCollege of Biomedical and Life Sciences School of Optometry and Vision SciencesCardiff UniversityAll clinical treatments are underpinned by basic scientific research, sometimes retrospectively, but mostly by forward planning and development, and the UK has historically...
2.3 Handheld Oximetric Ophthalmoscope for Enhanced Diagnosis of Retinopathy of Prematurity – Professor Andrew I McNaught
Handheld Oximetric Ophthalmoscope for Enhanced Diagnosis of Retinopathy of PrematurityProfessor Andrew I McNaughtHonorary Professor at the School of Health Sciences, Plymouth University. Consultant ophthalmologist – Cheltenham General HospitalRetinopathy of prematurity (ROP) is a potentially blinding condition that can lead to retinal detachment and blindness in severely premature and underweight babies....
2.2 Correcting mitochondrial decline and improving retinal function – implications for AMD as it reduces inflammation – Professor Glen Jeffery
Correcting mitochondrial decline and improving retinal function – implications for AMD as it reduces inflammationProfessor Glen JefferyProfessor of NeuroscienceInst Ophthalmology - Visual Neuroscience Institute of OphthalmologyFaculty of Brain SciencesThere is a growing body of evidence that the pace of aging is linked to metabolic rate, with high rates associated with...
2.1 How the application of machine learning and artificial intelligence (AI) can assist in the speed and quality of diagnosis – Dr Pearse A Keane
How the application of machine learning and artificial intelligence (AI) can assist in the speed and quality of diagnosisDr Pearse A KeaneNIHR Clinician Scientist and Honorary Consultant Ophthalmologist NIHR Biomedical Research CentreMoorfields Eye Hospital NHS Foundation Trust andUCL Institute of OphthalmologyA collaborative Research venture is now progressing between Moorfield Hospital’s...
1.3 The importance of earlier interventions and alternative treatments – John Greenwood
The importance of earlier interventions and alternative treatmentsJohn Greenwood PhD FRCPathHugh Davson Professor of Biomedical Research Head of Department of Cell BiologyUCL Institute of OphthalmologyUniversity College LondonDespite enormous progress in recent years in treating eye disease there remains an urgent clinical need for new therapies, especially those that intervene early...
1.2 The genetic revolution – Dr Denize Atan
The genetic revolutionDr Denize AtanSOCS Lead for Women in Science Consultant Senior Lecturer in Ophthalmology School of Clinical SciencesF38, Biomedical Sciences Building University of BristolWe are in the midst of a genetic revolution. Advances such as the Human Genome Project, HapMap, 1000 genomes and innovations in sequencing technology mean that...
In recognition of World Sight Day 2017
In recognition of World Sight Day on 12 October 2017, VisionBridge is delighted to feature some extraordinary examples of innovation, discovery and achievement from the world of eye research. VisionBridge continues to support those pioneers in eye research who work tirelessly to prevent sight loss, treat eye disease, restore sight and improve...
1.1 The case for basic science – Professor Alan Stitt
The case for basic science Professor Alan Stitt,Dean of Innovation & Impact,McCauley Chair of Experimental Ophthalmology Centre for Experimental MedicineThe Wellcome-Wolfson BuildingQueen's University Belfast Basic science underpins many mainstream therapeutics currently used to treat eye disease. It needs to remain clinically relevant and translatable into demonstrable benefits for patients if...